MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors

NCT02517398 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: MSB0011359C

Sponsor

EMD Serono Research & Development Institute, Inc.

Collaborators

[object Object]